Genentech, Xoma Beat Raptiva Warning Suit In 6th Circ.
The Sixth Circuit on Thursday dismissed a failure-to-warn suit against biotech companies Genentech Inc. and Xoma (U.S.) LLC over psoriasis treatment Raptiva, saying federal law preempts state law fraud-on-the-U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article